Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.
about
Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose InterferonSurvival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer.Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studiesImpact of systemic inflammation on gastric cancer outcomes.Determinant roles of gender and age on SII, PLR, NLR, LMR and MLR and their reference intervals defining in Henan, China: A posteriori and big-data-based.The Tumor-immune Index is Correlated With the Prognosis of Patients After Curative Resection for Nonsmall Cell Lung Cancer.Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study.Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolizationPostoperative Low Absolute Lymphocyte Counts may Predict Poor Outcomes of Hepatocellular Carcinoma After Liver ResectionPreoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancerSystemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation.Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer.Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junctionSystemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis.Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection.Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus.Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib.Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy.A novel prognostic index-neutrophil times γ-glutamyl transpeptidase to lymphocyte ratio (NγLR) predicts outcome for patients with hepatocellular carcinomaA novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma.Longer duration of the Pringle maneuver is associated with hepatocellular carcinoma recurrence following curative resection.Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection.Prognostic value of systemic immune-inflammation index in patients with gastric cancer.Synchronous splenectomy and hepatectomy for patients with small hepatocellular carcinoma and pathological spleen: neutrophil to lymphocyte ratio changes can predict the prognosis.Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma.The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.Systemic immune-inflammation index for predicting prognosis of colorectal cancer.Systemic immune-inflammation index predicts the clinical outcome in patients with nasopharyngeal carcinoma: a propensity score-matched analysis.Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer.Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis.Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody.Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma.Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients.The relative change in regulatory T cells / T helper lymphocytes ratio as parameter for prediction of therapy efficacy in metastatic colorectal cancer patients.The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib.
P2860
Q33820823-B5603444-B5E7-4A42-A284-4B178BB1ABE0Q33904496-5096977B-C911-48F8-8FDD-2604601DA6B0Q35956259-1800CA9E-1646-44F4-8BD4-DA5680356BF9Q36052780-BAB49B7D-98E9-4613-B3A4-2EEFBE3120CEQ36328544-55244A6B-C588-4681-A61C-C3A34E5F6FBEQ36335400-E80113B3-DA8B-4C99-8E25-AD8C6483EE5DQ36359123-31552E5D-D353-4084-857E-44E637C4B458Q36562386-6E3C2501-E608-4F6B-920D-957A18A5F606Q36619130-A48B25D3-50F5-48D5-BBA3-52ED77367AC4Q36720072-10172F27-84C4-429C-92F3-7A85A7BE371EQ37035451-275ADA41-ABF1-44EB-96B9-A6174D5F826AQ37335554-0ABCC2E2-A702-4143-8E4F-BB1A284DAB12Q37354173-6F223B5D-2569-4082-BC8A-C5EC6094A832Q37362884-E7E10FCD-6837-44B7-A018-27A26A28DC54Q37391008-22039A48-6E32-4258-B88A-4638DFB8514DQ37522481-C3D677B7-049E-4B1C-8114-0FAA57BBBC86Q37536826-01146C6C-5C5C-4D69-BA59-082705CED106Q37619533-DE6F4446-12B2-4330-8FCE-31C6C4DA1CF3Q37687133-9144AE98-F370-4FAB-8AE7-6BB2670840D9Q37688103-B1164801-FB0F-443F-A561-858DB514BDA9Q37718250-05532FF0-1CB7-42AB-AECD-14284AB711B4Q38611103-DAAA6C86-405F-436D-A07F-17422DDE3F2CQ38732038-F6B7A125-127B-4B25-A122-AA38200C70D2Q40778578-55791B87-D56B-4B36-9BEA-BD55231A7A46Q41037922-DE40F0B8-A61D-45D2-BB85-54F76462E575Q41152020-87FD1735-67FE-4AA6-B3E7-72B6606CC044Q41234120-2B62AE0C-830E-48D9-B29E-F3C629E3E5D6Q41942214-5E1D2774-DBFE-48B0-9E1C-52DC00FBDE9AQ42031892-2C850003-DCD6-4C07-BAE0-A0FED345AE37Q42360454-6353B10E-F295-4293-9865-DA4392A01A24Q42371608-E1C6A194-B8C0-4C73-AEB9-30F4F777C318Q43143206-518ED5AC-F8EC-4FF6-8576-86B78D4681BDQ45287349-D74F8FA7-49F0-4DE8-93E8-E8AA65B00991Q47113791-D7E34A8F-264F-48F3-A8DB-F92A7BBC24DBQ47331134-4C5368CD-092E-4CD8-B11A-C9B47FF72B16Q47621525-5CF62FDF-FD38-4ABA-AD38-1D2180037736Q48123565-EABCA06E-27C6-4550-B4F3-8BADCBB9179EQ48333900-BF8E1442-6098-4022-A733-951AC3B24970Q49163652-2F87A1F4-E8D4-4912-A88C-556FBAD77C2CQ49211015-AEA55629-D87F-4C4A-842C-723A26FC9004
P2860
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Systemic immune-inflammation i ...... for hepatocellular carcinoma.
@en
Systemic immune-inflammation i ...... for hepatocellular carcinoma.
@nl
type
label
Systemic immune-inflammation i ...... for hepatocellular carcinoma.
@en
Systemic immune-inflammation i ...... for hepatocellular carcinoma.
@nl
prefLabel
Systemic immune-inflammation i ...... for hepatocellular carcinoma.
@en
Systemic immune-inflammation i ...... for hepatocellular carcinoma.
@nl
P2093
P1476
Systemic immune-inflammation i ...... for hepatocellular carcinoma.
@en
P2093
Shuang-Jian Qiu
Wei-Min Wang
Xin-Rong Yang
Yun-Fan Sun
P304
P356
10.1158/1078-0432.CCR-14-0442
P407
P50
P577
2014-09-30T00:00:00Z